Barrier Therapeutics, Inc. - SWOT Analysis
Datamonitor's Barrier Therapeutics, Inc. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Barrier Therapeutics (Barrier) is a pharmaceutical company focused on the development and commercialization of pharmaceutical products in the field of dermatology. The company addresses medical needs in the treatment of dermatological diseases and disorders of the skin. The company operates in the US, Canada and Belgium. Barrier is headquartered in Princeton, New Jersey and employs 93 people. The company recorded revenues of $6.7 million during the fiscal year ended December 2006, as compared to $2.5 million in 2005. The operating loss of the company was $56.4 million during fiscal year 2006, as compared to an operating loss of $48.7 million in 2005. The net loss was $52.7 million in fiscal year 2006 as compared to a net loss of $45.2 million in 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
RELATED REPORTS
This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in Millions of US$. The specific product segments analyzed are Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs) and Nebulizers. The report provides separate comprehensive analytics for the US, Canada, Japan, ...
Industries : Pharmaceutical, Pathology | Countries : Canada, USA, Japan, Russia, Germany, Spain, France, Italy, United Kingdom, Switzerland
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Pharmaceutical | Countries : Canada, USA
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry ...
Industries : Pharmaceutical | Countries : Canada, USA
Cigarette smoking is the most important source of preventable and premature morbidity worldwide. Currently, the number of smokers across the globe is estimated at 1.3 billion. Political moves are leading to national bans of smoking in public places, with the long-term aim to reduce the cost to the h ...
Industries : Pharmaceutical | Countries : Canada, USA, Japan, Sweden, Germany, Spain, France, Italy, United Kingdom, Australia
``Parallel Trade acts as an important driving force for market integration where there are important differences in price between member states``- European Commission Communication on the single market in pharmaceuticalsParallel trade is on the verge of breaking its confines of the EU and diffusing ...
Industries : Pharmaceutical | Countries : Mexico, Canada, USA, Cyprus, Denmark, Norway, Sweden, Germany, United Kingdom
With 4 drugs now in the marketplace (a 100% rise from 2 years ago), the cannabinoid market continues to grow. Attitudes to the drugs are changing ensuring greater market penetration, and the first cannabinoid blockbuster is now a certainty.4 drugs already available: * Marinol® (dronabinol) * ...
Industries : Pharmaceutical | Countries : Canada, USA, Germany, Spain, France, Italy, United Kingdom
Over 160+ pages dedicated to tissue engineering and stem cell analysis.The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued h ...
Industries : Biotechnology, Pharmaceutical, Pathology | Countries : Canada, USA, United Kingdom
The news has been full of industry developments and financial investments in stem cell research in recent weeks. Your company must be aware of the latest developments immediately. * Researchers Find New Source For Stem Cells That Could End Debate * Brain stem cells against cancer? * 'Bio-in ...
Industries : Pathology, Biotechnology, Pharmaceutical | Countries : Canada, USA, United Kingdom
Related industries
reportlinker.com © Copyright 2009. All rights reserved